Systemic inflammation, myocardial fibrosis, and subclinical cardiovascular disease in people living with HIV
Authors:
Open Access
- 5 March 2026
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 297, 107399
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Veterans Affairs
- Division of Intramural Research
This publication has 17 references indexed in Scilit:
- 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of MyocarditisJACC, 2024
- Multimodality Imaging Assessment of Myocardial FibrosisJACC: Cardiovascular Imaging, 2021
- Myocardial Fibrosis and Inflammation by CMR Predict Cardiovascular Outcome in People Living With HIVJACC: Cardiovascular Imaging, 2021
- Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1JACC: Cardiovascular Imaging, 2020
- Cardiac Dysfunction Among People Living With HIVJACC: Heart Failure, 2019
- Brief Report: Statin Effects on Myocardial Fibrosis Markers in People Living With HIVJAIDS Journal of Acquired Immune Deficiency Syndromes, 2018
- Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy EraJAMA Cardiology, 2017
- Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected IndividualsJACC: Heart Failure, 2015
- Accelerated biological ageing in HIV-infected individuals in South AfricaAIDS, 2013
- Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen speciesCardiovascular Research, 2007